Oxford Names Blumberg As Balliol Master

In a break with tradition, Balliol College, one of Oxford University’s 35 colleges, has named Baruch S. Blumberg of Philadelphia, Pa., as its next Master. Nobel prizewinner Blumberg is both the first United States citizen and the first scientist elected to head the college, which traditionally chooses scholars from the humanities. Succeeding medieval philosopher Anthony Kenny, Blumberg, vice president of population oncology at Fox Chase Cancer Center, will assume the mastership in Sept

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In a break with tradition, Balliol College, one of Oxford University’s 35 colleges, has named Baruch S. Blumberg of Philadelphia, Pa., as its next Master. Nobel prizewinner Blumberg is both the first United States citizen and the first scientist elected to head the college, which traditionally chooses scholars from the humanities.

Succeeding medieval philosopher Anthony Kenny, Blumberg, vice president of population oncology at Fox Chase Cancer Center, will assume the mastership in September 1989. At that time, Kenny will leave to become secretary of the Rhodes Trust, which administers the Rhodes scholarship pro- gram.

In deciding to elect Blumberg, Balliol’s fellows were influenced not only by his distinguished scientific career, but also by his fundraising contacts in U.S. universities and industry. This fall, Oxford will launch an international campaign to raise more than $176 mil- lion. As master, Blumberg will be expected to spend a substantial part of the year ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies